Kennon Heard
Concepts (635)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Acetaminophen | 39 | 2023 | 237 | 8.970 |
Why?
| Chemical and Drug Induced Liver Injury | 15 | 2023 | 126 | 5.070 |
Why?
| Analgesics, Non-Narcotic | 20 | 2022 | 117 | 4.640 |
Why?
| Drug Overdose | 30 | 2022 | 296 | 4.340 |
Why?
| Emergency Service, Hospital | 40 | 2023 | 1829 | 3.790 |
Why?
| Poisoning | 17 | 2017 | 110 | 3.230 |
Why?
| Poison Control Centers | 11 | 2023 | 84 | 2.820 |
Why?
| Alanine Transaminase | 14 | 2023 | 141 | 2.770 |
Why?
| Acetylcysteine | 11 | 2023 | 144 | 2.740 |
Why?
| Cannabis | 9 | 2020 | 381 | 2.630 |
Why?
| Cocaine | 10 | 2011 | 153 | 2.590 |
Why?
| Prescription Drugs | 9 | 2018 | 116 | 2.350 |
Why?
| Analgesics, Opioid | 8 | 2023 | 783 | 1.750 |
Why?
| Antidotes | 9 | 2020 | 135 | 1.620 |
Why?
| Legislation, Drug | 5 | 2017 | 73 | 1.580 |
Why?
| Cysteine | 4 | 2017 | 173 | 1.480 |
Why?
| Antipsychotic Agents | 7 | 2019 | 183 | 1.420 |
Why?
| Marijuana Use | 4 | 2021 | 164 | 1.350 |
Why?
| Male | 101 | 2022 | 55949 | 1.320 |
Why?
| Medication Errors | 5 | 2015 | 89 | 1.240 |
Why?
| Humans | 152 | 2023 | 115587 | 1.220 |
Why?
| Cocaine-Related Disorders | 5 | 2011 | 107 | 1.170 |
Why?
| Pain | 9 | 2020 | 712 | 1.160 |
Why?
| Female | 95 | 2022 | 59913 | 1.150 |
Why?
| Emergency Medicine | 6 | 2019 | 227 | 1.150 |
Why?
| Adult | 73 | 2022 | 30718 | 1.150 |
Why?
| Toxicology | 4 | 2021 | 36 | 1.140 |
Why?
| Drug Packaging | 2 | 2017 | 43 | 1.130 |
Why?
| Medication Reconciliation | 2 | 2016 | 25 | 1.030 |
Why?
| Dose-Response Relationship, Drug | 16 | 2017 | 1870 | 1.010 |
Why?
| Antidepressive Agents, Tricyclic | 5 | 2014 | 29 | 0.950 |
Why?
| Spider Bites | 5 | 2019 | 10 | 0.940 |
Why?
| Diphenhydramine | 4 | 2023 | 30 | 0.940 |
Why?
| Middle Aged | 54 | 2022 | 26999 | 0.930 |
Why?
| Akathisia, Drug-Induced | 2 | 2020 | 6 | 0.920 |
Why?
| Young Adult | 30 | 2020 | 10470 | 0.910 |
Why?
| Antivenins | 5 | 2019 | 56 | 0.910 |
Why?
| Thiazoles | 4 | 2009 | 110 | 0.900 |
Why?
| Prescription Drug Monitoring Programs | 1 | 2023 | 13 | 0.880 |
Why?
| Spider Venoms | 4 | 2019 | 12 | 0.880 |
Why?
| Heart Arrest | 8 | 2018 | 289 | 0.870 |
Why?
| Referral and Consultation | 2 | 2020 | 646 | 0.850 |
Why?
| Benzodiazepines | 5 | 2011 | 115 | 0.850 |
Why?
| Muscarinic Antagonists | 3 | 2023 | 27 | 0.840 |
Why?
| Decision Support Systems, Clinical | 2 | 2023 | 179 | 0.840 |
Why?
| Seizures | 6 | 2011 | 344 | 0.830 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2019 | 301 | 0.800 |
Why?
| Piperazines | 4 | 2009 | 314 | 0.790 |
Why?
| Physostigmine | 2 | 2020 | 10 | 0.790 |
Why?
| Lorazepam | 2 | 2020 | 23 | 0.780 |
Why?
| Emergency Treatment | 4 | 2015 | 113 | 0.780 |
Why?
| Delirium | 2 | 2020 | 66 | 0.780 |
Why?
| Black Widow Spider | 4 | 2019 | 9 | 0.770 |
Why?
| Medical History Taking | 3 | 2018 | 114 | 0.770 |
Why?
| Dopamine Uptake Inhibitors | 3 | 2011 | 54 | 0.760 |
Why?
| Suicide, Attempted | 5 | 2012 | 316 | 0.740 |
Why?
| Abdominal Pain | 2 | 2019 | 135 | 0.730 |
Why?
| Anti-Arrhythmia Agents | 4 | 2014 | 106 | 0.720 |
Why?
| Retrospective Studies | 30 | 2022 | 12608 | 0.720 |
Why?
| Hospitals, Pediatric | 4 | 2018 | 478 | 0.710 |
Why?
| Back Pain | 1 | 2020 | 44 | 0.700 |
Why?
| Vasoconstrictor Agents | 4 | 2009 | 113 | 0.700 |
Why?
| Buprenorphine | 2 | 2020 | 138 | 0.690 |
Why?
| Patient Handoff | 1 | 2020 | 27 | 0.680 |
Why?
| Free Radical Scavengers | 2 | 2011 | 82 | 0.680 |
Why?
| Ketorolac | 1 | 2019 | 17 | 0.660 |
Why?
| Haloperidol | 1 | 2019 | 35 | 0.660 |
Why?
| Social Work | 1 | 2020 | 75 | 0.650 |
Why?
| Prospective Studies | 18 | 2023 | 6264 | 0.650 |
Why?
| Pharmacoepidemiology | 1 | 2018 | 20 | 0.640 |
Why?
| Colorado | 15 | 2021 | 4113 | 0.640 |
Why?
| Substance-Related Disorders | 5 | 2012 | 950 | 0.630 |
Why?
| Tertiary Care Centers | 3 | 2017 | 127 | 0.630 |
Why?
| Child | 28 | 2023 | 18488 | 0.620 |
Why?
| Gastric Lavage | 3 | 2009 | 9 | 0.620 |
Why?
| Vomiting | 6 | 2019 | 125 | 0.620 |
Why?
| Immunoglobulin Fab Fragments | 4 | 2019 | 69 | 0.610 |
Why?
| Cannabinoids | 3 | 2017 | 116 | 0.590 |
Why?
| Hypotension | 2 | 2022 | 115 | 0.590 |
Why?
| Drug Storage | 2 | 2017 | 58 | 0.590 |
Why?
| Accidents, Home | 1 | 2017 | 29 | 0.580 |
Why?
| Medical Marijuana | 2 | 2019 | 97 | 0.580 |
Why?
| Pulmonary Embolism | 3 | 2021 | 182 | 0.570 |
Why?
| Plant Preparations | 2 | 2015 | 23 | 0.570 |
Why?
| Fibrin Fibrinogen Degradation Products | 2 | 2007 | 81 | 0.560 |
Why?
| Calcium Gluconate | 1 | 2016 | 4 | 0.560 |
Why?
| Quaternary Ammonium Compounds | 1 | 2016 | 45 | 0.550 |
Why?
| Mobile Applications | 1 | 2018 | 140 | 0.540 |
Why?
| Hypocalcemia | 1 | 2016 | 31 | 0.540 |
Why?
| Health Records, Personal | 1 | 2016 | 24 | 0.540 |
Why?
| Practice Patterns, Physicians' | 3 | 2023 | 1180 | 0.530 |
Why?
| Nonprescription Drugs | 4 | 2016 | 68 | 0.520 |
Why?
| Treatment Outcome | 18 | 2020 | 9159 | 0.520 |
Why?
| Liver | 6 | 2022 | 1690 | 0.520 |
Why?
| Antidepressive Agents | 2 | 2012 | 195 | 0.520 |
Why?
| Blood Proteins | 1 | 2017 | 238 | 0.520 |
Why?
| Child, Preschool | 13 | 2018 | 9133 | 0.520 |
Why?
| Fat Emulsions, Intravenous | 2 | 2014 | 30 | 0.510 |
Why?
| Drug-Related Side Effects and Adverse Reactions | 5 | 2023 | 242 | 0.510 |
Why?
| Prescription Drug Misuse | 1 | 2015 | 38 | 0.500 |
Why?
| Infant | 12 | 2018 | 7979 | 0.500 |
Why?
| Emergency Medical Services | 4 | 2016 | 590 | 0.500 |
Why?
| Electrocardiography | 5 | 2013 | 560 | 0.490 |
Why?
| Adolescent | 27 | 2020 | 17889 | 0.480 |
Why?
| Electronic Health Records | 3 | 2023 | 805 | 0.470 |
Why?
| Asymptomatic Diseases | 2 | 2013 | 77 | 0.460 |
Why?
| Observer Variation | 3 | 2010 | 297 | 0.460 |
Why?
| Crime | 2 | 2011 | 59 | 0.460 |
Why?
| Double-Blind Method | 7 | 2020 | 1660 | 0.450 |
Why?
| Arrhythmias, Cardiac | 3 | 2022 | 279 | 0.450 |
Why?
| Adrenergic alpha-2 Receptor Agonists | 1 | 2013 | 24 | 0.450 |
Why?
| Energy Drinks | 1 | 2013 | 4 | 0.450 |
Why?
| Performance-Enhancing Substances | 1 | 2013 | 7 | 0.440 |
Why?
| Aged | 27 | 2019 | 19251 | 0.440 |
Why?
| Accidents | 1 | 2013 | 40 | 0.440 |
Why?
| Bradycardia | 1 | 2013 | 48 | 0.440 |
Why?
| Dronabinol | 4 | 2021 | 118 | 0.430 |
Why?
| Diet Surveys | 1 | 2013 | 78 | 0.430 |
Why?
| Poisons | 2 | 2023 | 21 | 0.430 |
Why?
| Plasmapheresis | 1 | 2013 | 22 | 0.430 |
Why?
| Hematemesis | 1 | 2012 | 3 | 0.430 |
Why?
| Amphotericin B | 1 | 2013 | 32 | 0.430 |
Why?
| Phytotherapy | 1 | 2013 | 66 | 0.430 |
Why?
| beta-Alanine | 1 | 2012 | 18 | 0.430 |
Why?
| Stomach Diseases | 1 | 2012 | 19 | 0.420 |
Why?
| Aspartate Aminotransferases | 3 | 2010 | 87 | 0.420 |
Why?
| Foreign Bodies | 2 | 2011 | 99 | 0.420 |
Why?
| Ethers | 1 | 2012 | 16 | 0.420 |
Why?
| Sulfonylurea Compounds | 2 | 2010 | 44 | 0.420 |
Why?
| Alcohol Drinking | 4 | 2012 | 648 | 0.420 |
Why?
| Disease Models, Animal | 9 | 2011 | 3580 | 0.420 |
Why?
| Antithrombins | 1 | 2012 | 49 | 0.420 |
Why?
| Citalopram | 1 | 2012 | 27 | 0.410 |
Why?
| Liver Function Tests | 7 | 2020 | 105 | 0.410 |
Why?
| Genetic Predisposition to Disease | 1 | 2020 | 2125 | 0.410 |
Why?
| Drug Administration Schedule | 5 | 2014 | 724 | 0.410 |
Why?
| Opioid-Related Disorders | 2 | 2020 | 422 | 0.410 |
Why?
| C-Peptide | 2 | 2010 | 138 | 0.400 |
Why?
| Antifungal Agents | 1 | 2013 | 133 | 0.400 |
Why?
| Propafenone | 1 | 2011 | 2 | 0.400 |
Why?
| Thiophenes | 1 | 2012 | 109 | 0.400 |
Why?
| Burns | 2 | 2015 | 242 | 0.400 |
Why?
| Aged, 80 and over | 15 | 2018 | 6417 | 0.400 |
Why?
| Benzimidazoles | 1 | 2012 | 137 | 0.390 |
Why?
| Firesetting Behavior | 1 | 2011 | 1 | 0.390 |
Why?
| Infusions, Intravenous | 6 | 2013 | 374 | 0.390 |
Why?
| Charcoal | 4 | 2006 | 22 | 0.390 |
Why?
| Clinical Enzyme Tests | 2 | 2013 | 11 | 0.390 |
Why?
| Temperance | 2 | 2010 | 14 | 0.380 |
Why?
| Administration, Intravenous | 4 | 2016 | 126 | 0.380 |
Why?
| Chemical and Drug Induced Liver Injury, Chronic | 1 | 2011 | 9 | 0.380 |
Why?
| Brain Edema | 1 | 2011 | 59 | 0.370 |
Why?
| Cholinergic Antagonists | 1 | 2011 | 27 | 0.370 |
Why?
| Self-Injurious Behavior | 1 | 2012 | 114 | 0.370 |
Why?
| Evidence-Based Medicine | 4 | 2023 | 684 | 0.370 |
Why?
| Amitriptyline | 2 | 2001 | 21 | 0.370 |
Why?
| Blood Chemical Analysis | 3 | 2021 | 90 | 0.370 |
Why?
| Immunologic Factors | 2 | 2019 | 220 | 0.370 |
Why?
| Liver Failure | 1 | 2011 | 84 | 0.360 |
Why?
| Population Surveillance | 1 | 2013 | 395 | 0.360 |
Why?
| Tachycardia, Ventricular | 1 | 2012 | 152 | 0.360 |
Why?
| Time Factors | 12 | 2020 | 6165 | 0.360 |
Why?
| Anaphylaxis | 2 | 2012 | 148 | 0.360 |
Why?
| Cross-Sectional Studies | 9 | 2020 | 4435 | 0.360 |
Why?
| United States | 17 | 2023 | 12295 | 0.360 |
Why?
| Hydrofluoric Acid | 2 | 2016 | 8 | 0.360 |
Why?
| Pharmaceutical Vehicles | 1 | 2010 | 11 | 0.350 |
Why?
| Propylene Glycol | 1 | 2010 | 9 | 0.350 |
Why?
| Surveys and Questionnaires | 4 | 2018 | 4665 | 0.350 |
Why?
| Barium | 1 | 2009 | 25 | 0.350 |
Why?
| Acidosis, Lactic | 1 | 2010 | 29 | 0.350 |
Why?
| Risk Factors | 9 | 2017 | 8697 | 0.350 |
Why?
| Explosive Agents | 1 | 2009 | 9 | 0.350 |
Why?
| Warfarin | 1 | 2010 | 136 | 0.340 |
Why?
| Liver Diseases, Alcoholic | 2 | 2007 | 85 | 0.340 |
Why?
| Hypokalemia | 1 | 2009 | 25 | 0.340 |
Why?
| Imines | 2 | 2022 | 7 | 0.340 |
Why?
| Length of Stay | 3 | 2020 | 958 | 0.340 |
Why?
| Iatrogenic Disease | 1 | 2010 | 51 | 0.340 |
Why?
| Emetics | 2 | 2006 | 7 | 0.340 |
Why?
| Deception | 1 | 2009 | 16 | 0.340 |
Why?
| Random Allocation | 3 | 2007 | 337 | 0.330 |
Why?
| Risk Assessment | 8 | 2017 | 2987 | 0.330 |
Why?
| Benzoquinones | 2 | 2022 | 44 | 0.330 |
Why?
| Oximetry | 1 | 2009 | 80 | 0.330 |
Why?
| Odds Ratio | 7 | 2017 | 962 | 0.320 |
Why?
| Hypothermia, Induced | 1 | 2009 | 69 | 0.320 |
Why?
| Point-of-Care Systems | 1 | 2010 | 141 | 0.320 |
Why?
| Intellectual Disability | 1 | 2009 | 129 | 0.310 |
Why?
| Hypoglycemia | 2 | 2010 | 386 | 0.310 |
Why?
| Eyelashes | 1 | 2008 | 3 | 0.310 |
Why?
| Cyanoacrylates | 1 | 2008 | 4 | 0.310 |
Why?
| Reference Values | 4 | 2017 | 744 | 0.310 |
Why?
| Animals | 20 | 2019 | 32102 | 0.300 |
Why?
| Adhesives | 1 | 2008 | 11 | 0.300 |
Why?
| Detergents | 1 | 2008 | 41 | 0.300 |
Why?
| Cardiovascular System | 1 | 2009 | 124 | 0.300 |
Why?
| Polyethylene Glycols | 1 | 2012 | 576 | 0.300 |
Why?
| Publishing | 1 | 2009 | 127 | 0.300 |
Why?
| Brugada Syndrome | 1 | 2007 | 9 | 0.290 |
Why?
| Clinical Laboratory Techniques | 1 | 2008 | 87 | 0.290 |
Why?
| Diazepam | 1 | 2007 | 27 | 0.290 |
Why?
| Niacin | 1 | 2007 | 19 | 0.290 |
Why?
| Pediatrics | 1 | 2015 | 986 | 0.280 |
Why?
| Mice, Inbred Strains | 4 | 2009 | 399 | 0.280 |
Why?
| Vitamin B Complex | 1 | 2007 | 37 | 0.280 |
Why?
| Specimen Handling | 1 | 2008 | 156 | 0.280 |
Why?
| Thromboembolism | 1 | 2007 | 93 | 0.280 |
Why?
| Analgesics | 4 | 2017 | 157 | 0.280 |
Why?
| Brain Infarction | 1 | 2006 | 22 | 0.280 |
Why?
| Anticoagulants | 1 | 2010 | 549 | 0.270 |
Why?
| Self Report | 4 | 2021 | 698 | 0.270 |
Why?
| Hypoxia-Ischemia, Brain | 1 | 2006 | 26 | 0.270 |
Why?
| Randomized Controlled Trials as Topic | 5 | 2012 | 1216 | 0.270 |
Why?
| Nausea | 4 | 2014 | 103 | 0.270 |
Why?
| Age Factors | 7 | 2017 | 2907 | 0.270 |
Why?
| Acute Kidney Injury | 1 | 2012 | 646 | 0.260 |
Why?
| Intention | 1 | 2007 | 143 | 0.260 |
Why?
| Decontamination | 1 | 2006 | 23 | 0.260 |
Why?
| Amiodarone | 1 | 2005 | 23 | 0.260 |
Why?
| Databases, Factual | 1 | 2010 | 1138 | 0.260 |
Why?
| Venous Thrombosis | 1 | 2007 | 145 | 0.260 |
Why?
| Epilepsy | 2 | 2020 | 290 | 0.260 |
Why?
| Eating | 4 | 2017 | 346 | 0.260 |
Why?
| Vasospasm, Intracranial | 1 | 2005 | 17 | 0.250 |
Why?
| Biomarkers | 7 | 2021 | 3466 | 0.250 |
Why?
| Hypoglycemic Agents | 2 | 2010 | 1008 | 0.250 |
Why?
| Sodium Nitrite | 1 | 2005 | 37 | 0.250 |
Why?
| Education, Medical | 2 | 2021 | 225 | 0.250 |
Why?
| Drug Utilization | 5 | 2014 | 167 | 0.250 |
Why?
| Subarachnoid Hemorrhage | 1 | 2005 | 60 | 0.250 |
Why?
| Diagnostic Imaging | 1 | 2007 | 296 | 0.240 |
Why?
| Coma | 2 | 2006 | 30 | 0.240 |
Why?
| Reproducibility of Results | 5 | 2011 | 2800 | 0.240 |
Why?
| Insulin | 3 | 2019 | 2082 | 0.240 |
Why?
| Case-Control Studies | 4 | 2022 | 3022 | 0.230 |
Why?
| Hospitals, Urban | 5 | 2021 | 129 | 0.230 |
Why?
| Injections, Intraperitoneal | 4 | 2009 | 104 | 0.230 |
Why?
| Glasgow Coma Scale | 1 | 2004 | 144 | 0.220 |
Why?
| Anti-Anxiety Agents | 2 | 2020 | 44 | 0.220 |
Why?
| Animal Experimentation | 1 | 2003 | 6 | 0.220 |
Why?
| Fibrinolytic Agents | 2 | 2021 | 233 | 0.220 |
Why?
| Calcium Chloride | 1 | 2003 | 15 | 0.220 |
Why?
| Sensitivity and Specificity | 4 | 2010 | 1718 | 0.210 |
Why?
| Hospitals, Teaching | 3 | 2014 | 103 | 0.210 |
Why?
| Magnesium Sulfate | 1 | 2003 | 17 | 0.210 |
Why?
| Longevity | 3 | 2009 | 136 | 0.210 |
Why?
| Cardiopulmonary Resuscitation | 3 | 2018 | 220 | 0.210 |
Why?
| Umbilical Cord | 2 | 2021 | 80 | 0.200 |
Why?
| Placebos | 2 | 2014 | 198 | 0.200 |
Why?
| Logistic Models | 3 | 2017 | 1856 | 0.200 |
Why?
| Opiate Substitution Treatment | 2 | 2020 | 102 | 0.200 |
Why?
| Desipramine | 1 | 2001 | 9 | 0.200 |
Why?
| Phenylurea Compounds | 1 | 2022 | 83 | 0.200 |
Why?
| Severity of Illness Index | 1 | 2009 | 2578 | 0.200 |
Why?
| Hyperthermia, Induced | 1 | 2022 | 65 | 0.200 |
Why?
| Research Design | 3 | 2006 | 946 | 0.200 |
Why?
| Narcotic Antagonists | 2 | 2020 | 139 | 0.190 |
Why?
| Confidence Intervals | 4 | 2010 | 309 | 0.190 |
Why?
| Sinus Thrombosis, Intracranial | 1 | 2021 | 22 | 0.190 |
Why?
| Heart Atria | 1 | 2001 | 110 | 0.190 |
Why?
| Fractures, Bone | 2 | 2017 | 372 | 0.190 |
Why?
| Acute Disease | 2 | 2019 | 914 | 0.180 |
Why?
| Myocardial Contraction | 1 | 2001 | 316 | 0.180 |
Why?
| Mass Screening | 1 | 2007 | 1024 | 0.170 |
Why?
| Immunoglobulin Fragments | 1 | 1999 | 15 | 0.170 |
Why?
| Lysergic Acid Diethylamide | 1 | 1999 | 2 | 0.170 |
Why?
| Droperidol | 1 | 1999 | 4 | 0.170 |
Why?
| Wisconsin | 1 | 2020 | 91 | 0.170 |
Why?
| Lithium Carbonate | 1 | 1999 | 6 | 0.170 |
Why?
| Serotonin Syndrome | 1 | 1999 | 5 | 0.170 |
Why?
| Starch | 1 | 2019 | 20 | 0.170 |
Why?
| Scorpion Stings | 1 | 1999 | 1 | 0.170 |
Why?
| Serotonin Receptor Agonists | 1 | 1999 | 27 | 0.170 |
Why?
| Geriatric Assessment | 2 | 2011 | 176 | 0.170 |
Why?
| Nutritive Value | 1 | 2019 | 30 | 0.170 |
Why?
| Community Health Workers | 1 | 2020 | 46 | 0.170 |
Why?
| Ventricular Premature Complexes | 1 | 1999 | 26 | 0.170 |
Why?
| Thrombocytopenia | 1 | 2021 | 175 | 0.170 |
Why?
| Administration, Oral | 4 | 2019 | 734 | 0.170 |
Why?
| Cannabidiol | 1 | 2020 | 59 | 0.170 |
Why?
| Healthy Volunteers | 2 | 2019 | 192 | 0.170 |
Why?
| Metabolome | 1 | 2022 | 287 | 0.170 |
Why?
| Immune System | 1 | 2020 | 173 | 0.170 |
Why?
| Cohort Studies | 7 | 2023 | 4944 | 0.160 |
Why?
| Fallopian Tube Diseases | 1 | 1998 | 5 | 0.160 |
Why?
| Pregnancy, Tubal | 1 | 1998 | 5 | 0.160 |
Why?
| Alcoholism | 3 | 2011 | 713 | 0.160 |
Why?
| Sex Factors | 5 | 2022 | 1736 | 0.160 |
Why?
| Dietary Carbohydrates | 1 | 2019 | 135 | 0.160 |
Why?
| Abortifacient Agents, Nonsteroidal | 1 | 1998 | 19 | 0.160 |
Why?
| Munchausen Syndrome by Proxy | 1 | 1998 | 2 | 0.160 |
Why?
| Plant Extracts | 1 | 2020 | 153 | 0.160 |
Why?
| Snake Bites | 1 | 1999 | 54 | 0.160 |
Why?
| Anticonvulsants | 1 | 2020 | 181 | 0.160 |
Why?
| Faculty, Medical | 1 | 2021 | 234 | 0.160 |
Why?
| Chi-Square Distribution | 2 | 2017 | 499 | 0.150 |
Why?
| Sulfasalazine | 1 | 1998 | 21 | 0.150 |
Why?
| Drug Antagonism | 2 | 2009 | 8 | 0.150 |
Why?
| Genome-Wide Association Study | 2 | 2023 | 1217 | 0.150 |
Why?
| Fellowships and Scholarships | 1 | 2021 | 241 | 0.150 |
Why?
| Dyspnea | 1 | 1999 | 223 | 0.150 |
Why?
| Drug Therapy, Combination | 3 | 2011 | 962 | 0.150 |
Why?
| Survival Rate | 3 | 2013 | 1650 | 0.150 |
Why?
| Out-of-Hospital Cardiac Arrest | 1 | 2018 | 78 | 0.150 |
Why?
| Drug Interactions | 4 | 2014 | 347 | 0.150 |
Why?
| Incidence | 4 | 2013 | 2335 | 0.150 |
Why?
| Dietary Fats | 1 | 2019 | 289 | 0.150 |
Why?
| Simulation Training | 1 | 2018 | 63 | 0.150 |
Why?
| Methotrexate | 1 | 1998 | 228 | 0.150 |
Why?
| Continuity of Patient Care | 1 | 2020 | 255 | 0.150 |
Why?
| Gastrointestinal Agents | 1 | 1998 | 60 | 0.150 |
Why?
| Hypnotics and Sedatives | 1 | 1998 | 134 | 0.140 |
Why?
| Peptide Fragments | 1 | 2021 | 675 | 0.140 |
Why?
| Energy Intake | 1 | 2019 | 414 | 0.140 |
Why?
| Pain Management | 2 | 2017 | 291 | 0.140 |
Why?
| Clinical Trials as Topic | 2 | 2012 | 941 | 0.140 |
Why?
| Ammonium Compounds | 1 | 2016 | 3 | 0.140 |
Why?
| Mice | 7 | 2009 | 15052 | 0.140 |
Why?
| Fluorides | 1 | 2016 | 45 | 0.140 |
Why?
| Predictive Value of Tests | 3 | 2015 | 1805 | 0.140 |
Why?
| Prenatal Care | 1 | 2019 | 257 | 0.140 |
Why?
| Cytochrome P-450 CYP2E1 Inhibitors | 1 | 2016 | 2 | 0.140 |
Why?
| Metabolic Clearance Rate | 2 | 2019 | 108 | 0.140 |
Why?
| Survival Analysis | 3 | 2010 | 1219 | 0.130 |
Why?
| Ventricular Fibrillation | 1 | 2016 | 51 | 0.130 |
Why?
| Half-Life | 2 | 2019 | 145 | 0.130 |
Why?
| Pharmacovigilance | 1 | 2015 | 14 | 0.130 |
Why?
| Pilot Projects | 1 | 2020 | 1377 | 0.130 |
Why?
| Herniorrhaphy | 1 | 2016 | 50 | 0.130 |
Why?
| Calcium | 2 | 2016 | 1103 | 0.130 |
Why?
| Milk | 1 | 2016 | 124 | 0.130 |
Why?
| Genetic Variation | 1 | 2020 | 877 | 0.130 |
Why?
| Adverse Drug Reaction Reporting Systems | 1 | 2015 | 69 | 0.130 |
Why?
| Fatal Outcome | 2 | 2013 | 286 | 0.130 |
Why?
| Models, Biological | 2 | 2015 | 1646 | 0.120 |
Why?
| Child Behavior | 1 | 2017 | 218 | 0.120 |
Why?
| Hemodialysis Units, Hospital | 1 | 1994 | 5 | 0.120 |
Why?
| Internship and Residency | 2 | 2014 | 951 | 0.120 |
Why?
| Liver Failure, Acute | 1 | 2015 | 60 | 0.120 |
Why?
| Ondansetron | 1 | 2014 | 8 | 0.120 |
Why?
| Patient Simulation | 1 | 2014 | 29 | 0.120 |
Why?
| Curriculum | 1 | 2021 | 852 | 0.120 |
Why?
| Hydrocodone | 1 | 2014 | 15 | 0.120 |
Why?
| Cytochrome P-450 CYP2D6 | 1 | 2014 | 24 | 0.120 |
Why?
| Personnel Staffing and Scheduling | 1 | 2015 | 79 | 0.120 |
Why?
| Total Quality Management | 1 | 1994 | 62 | 0.120 |
Why?
| Prognosis | 3 | 2011 | 3339 | 0.120 |
Why?
| Physicians | 2 | 2020 | 776 | 0.120 |
Why?
| Pregnancy Complications | 1 | 2019 | 430 | 0.120 |
Why?
| Transaminases | 1 | 2014 | 25 | 0.120 |
Why?
| Oxycodone | 1 | 2014 | 44 | 0.120 |
Why?
| Acute Pain | 1 | 2014 | 34 | 0.110 |
Why?
| Guanfacine | 1 | 2013 | 2 | 0.110 |
Why?
| Remote Consultation | 1 | 2014 | 42 | 0.110 |
Why?
| Vitamins | 1 | 2015 | 151 | 0.110 |
Why?
| Walking | 1 | 2017 | 425 | 0.110 |
Why?
| Clonidine | 1 | 2013 | 26 | 0.110 |
Why?
| International Normalized Ratio | 2 | 2011 | 45 | 0.110 |
Why?
| Indazoles | 1 | 2014 | 58 | 0.110 |
Why?
| Cesium | 1 | 2013 | 17 | 0.110 |
Why?
| Food | 1 | 2015 | 160 | 0.110 |
Why?
| Attitude of Health Personnel | 1 | 2020 | 990 | 0.110 |
Why?
| Deoxycholic Acid | 1 | 2013 | 15 | 0.110 |
Why?
| Pain Measurement | 4 | 2019 | 449 | 0.110 |
Why?
| Lethargy | 1 | 2012 | 4 | 0.110 |
Why?
| Duloxetine Hydrochloride | 1 | 2012 | 8 | 0.110 |
Why?
| Dabigatran | 1 | 2012 | 22 | 0.110 |
Why?
| Pyrazoles | 1 | 2016 | 362 | 0.110 |
Why?
| Athletic Performance | 1 | 2013 | 42 | 0.110 |
Why?
| Chlorides | 1 | 2013 | 130 | 0.110 |
Why?
| Marijuana Abuse | 1 | 2015 | 209 | 0.100 |
Why?
| Tachycardia | 1 | 2012 | 49 | 0.100 |
Why?
| Sleep Stages | 1 | 2012 | 61 | 0.100 |
Why?
| Mycoses | 1 | 2013 | 67 | 0.100 |
Why?
| Patient Discharge | 2 | 2016 | 770 | 0.100 |
Why?
| Sulfhydryl Reagents | 1 | 2012 | 11 | 0.100 |
Why?
| Dizziness | 1 | 2012 | 70 | 0.100 |
Why?
| Data Collection | 2 | 2013 | 636 | 0.100 |
Why?
| Accidental Falls | 2 | 2011 | 151 | 0.100 |
Why?
| Arsenicals | 1 | 2012 | 24 | 0.100 |
Why?
| Sampling Studies | 1 | 2012 | 95 | 0.100 |
Why?
| Drug Combinations | 1 | 2013 | 289 | 0.100 |
Why?
| Follow-Up Studies | 3 | 2010 | 4440 | 0.100 |
Why?
| Laparoscopy | 1 | 2016 | 400 | 0.100 |
Why?
| Information Systems | 1 | 2011 | 61 | 0.100 |
Why?
| Sulfides | 1 | 2012 | 94 | 0.100 |
Why?
| Marijuana Smoking | 1 | 2015 | 224 | 0.100 |
Why?
| Arabia | 1 | 2011 | 2 | 0.100 |
Why?
| Dietary Supplements | 1 | 2015 | 458 | 0.100 |
Why?
| Hepatic Encephalopathy | 1 | 2011 | 21 | 0.100 |
Why?
| Levamisole | 1 | 2011 | 20 | 0.090 |
Why?
| Structure-Activity Relationship | 1 | 2012 | 511 | 0.090 |
Why?
| Immunocompromised Host | 1 | 2013 | 197 | 0.090 |
Why?
| Drug Contamination | 1 | 2011 | 53 | 0.090 |
Why?
| Molecular Structure | 1 | 2012 | 447 | 0.090 |
Why?
| Sports | 1 | 2013 | 175 | 0.090 |
Why?
| Universities | 1 | 2013 | 340 | 0.090 |
Why?
| Pharmacogenetics | 1 | 2012 | 151 | 0.090 |
Why?
| Glipizide | 1 | 2010 | 6 | 0.090 |
Why?
| Laboratories, Hospital | 1 | 2010 | 13 | 0.090 |
Why?
| Hepatitis, Alcoholic | 1 | 2010 | 13 | 0.090 |
Why?
| Troponin | 1 | 2010 | 44 | 0.090 |
Why?
| Glyburide | 1 | 2010 | 35 | 0.090 |
Why?
| Drug Prescriptions | 2 | 2016 | 241 | 0.090 |
Why?
| Crowding | 1 | 2010 | 37 | 0.090 |
Why?
| Body Weight | 1 | 2014 | 867 | 0.090 |
Why?
| Watchful Waiting | 1 | 2010 | 57 | 0.090 |
Why?
| Adjuvants, Immunologic | 1 | 2011 | 206 | 0.090 |
Why?
| Intensive Care Units, Pediatric | 1 | 2011 | 147 | 0.090 |
Why?
| Quetiapine Fumarate | 1 | 2009 | 22 | 0.080 |
Why?
| Health Services Accessibility | 1 | 2015 | 771 | 0.080 |
Why?
| Dibenzothiazepines | 1 | 2009 | 17 | 0.080 |
Why?
| Aripiprazole | 1 | 2009 | 17 | 0.080 |
Why?
| Risperidone | 1 | 2009 | 26 | 0.080 |
Why?
| Renal Dialysis | 1 | 2013 | 369 | 0.080 |
Why?
| Potassium | 1 | 2009 | 128 | 0.080 |
Why?
| Dogs | 1 | 2010 | 341 | 0.080 |
Why?
| Efficiency, Organizational | 1 | 2010 | 126 | 0.080 |
Why?
| Role | 1 | 2009 | 32 | 0.080 |
Why?
| Head Protective Devices | 1 | 2009 | 15 | 0.080 |
Why?
| Glutathione | 3 | 2022 | 303 | 0.080 |
Why?
| Workload | 1 | 2010 | 133 | 0.080 |
Why?
| Quality Control | 1 | 2009 | 147 | 0.080 |
Why?
| Bibliometrics | 1 | 2009 | 45 | 0.080 |
Why?
| Body Temperature | 1 | 2009 | 211 | 0.080 |
Why?
| Acidosis | 2 | 2006 | 87 | 0.080 |
Why?
| Diarrhea | 1 | 2009 | 173 | 0.080 |
Why?
| Quality Indicators, Health Care | 1 | 2011 | 287 | 0.080 |
Why?
| Skiing | 1 | 2009 | 40 | 0.080 |
Why?
| Students | 1 | 2013 | 502 | 0.080 |
Why?
| Informed Consent | 2 | 2006 | 161 | 0.080 |
Why?
| Pharmacy Service, Hospital | 1 | 2009 | 84 | 0.080 |
Why?
| Acetone | 1 | 2008 | 10 | 0.080 |
Why?
| Hair Preparations | 1 | 2008 | 2 | 0.080 |
Why?
| Bacitracin | 1 | 2008 | 6 | 0.080 |
Why?
| Adhesiveness | 1 | 2008 | 19 | 0.080 |
Why?
| Cause of Death | 1 | 2010 | 368 | 0.080 |
Why?
| Nylons | 1 | 2008 | 18 | 0.080 |
Why?
| Propylene Glycols | 1 | 2008 | 26 | 0.080 |
Why?
| Quinolones | 1 | 2009 | 97 | 0.080 |
Why?
| Withholding Treatment | 1 | 2008 | 69 | 0.080 |
Why?
| Substance Abuse Detection | 2 | 2021 | 62 | 0.070 |
Why?
| Equipment Design | 1 | 2009 | 517 | 0.070 |
Why?
| Drug Synergism | 1 | 2008 | 317 | 0.070 |
Why?
| Glycerol | 1 | 2008 | 86 | 0.070 |
Why?
| Cellulose | 1 | 2008 | 61 | 0.070 |
Why?
| Nephelometry and Turbidimetry | 1 | 2007 | 16 | 0.070 |
Why?
| Laboratories | 1 | 2008 | 95 | 0.070 |
Why?
| Polypharmacy | 1 | 2008 | 74 | 0.070 |
Why?
| Hospitalization | 2 | 2011 | 1765 | 0.070 |
Why?
| Military Personnel | 1 | 2014 | 525 | 0.070 |
Why?
| Phosphates | 1 | 2008 | 160 | 0.070 |
Why?
| Tissue Distribution | 2 | 2019 | 324 | 0.070 |
Why?
| Research | 2 | 2011 | 396 | 0.070 |
Why?
| Periodicals as Topic | 1 | 2009 | 183 | 0.070 |
Why?
| Formates | 1 | 2006 | 11 | 0.070 |
Why?
| Kidney Transplantation | 1 | 2013 | 558 | 0.070 |
Why?
| Combined Modality Therapy | 1 | 2009 | 1127 | 0.070 |
Why?
| Methanol | 1 | 2006 | 30 | 0.070 |
Why?
| Defibrillators | 1 | 2006 | 16 | 0.070 |
Why?
| Aging | 2 | 2014 | 1631 | 0.070 |
Why?
| Blindness | 1 | 2006 | 37 | 0.070 |
Why?
| Vasopressins | 1 | 2006 | 57 | 0.070 |
Why?
| Statistics, Nonparametric | 1 | 2007 | 390 | 0.070 |
Why?
| Naproxen | 1 | 2006 | 11 | 0.070 |
Why?
| Telemedicine | 1 | 2014 | 667 | 0.070 |
Why?
| Probability | 2 | 2010 | 294 | 0.070 |
Why?
| Health Services for the Aged | 1 | 2006 | 70 | 0.070 |
Why?
| Respiratory Insufficiency | 1 | 2009 | 292 | 0.070 |
Why?
| Ipecac | 1 | 2005 | 8 | 0.070 |
Why?
| Spinal Diseases | 1 | 2006 | 45 | 0.070 |
Why?
| Population Dynamics | 1 | 2006 | 128 | 0.070 |
Why?
| Respiration, Artificial | 1 | 2009 | 526 | 0.070 |
Why?
| Geriatrics | 1 | 2006 | 69 | 0.060 |
Why?
| Epinephrine | 1 | 2006 | 167 | 0.060 |
Why?
| Ibuprofen | 1 | 2006 | 73 | 0.060 |
Why?
| Hospitals, University | 1 | 2006 | 172 | 0.060 |
Why?
| Practice Guidelines as Topic | 2 | 2014 | 1405 | 0.060 |
Why?
| Haplorhini | 1 | 2005 | 60 | 0.060 |
Why?
| Premedication | 1 | 2005 | 36 | 0.060 |
Why?
| Blood Glucose | 2 | 2019 | 1824 | 0.060 |
Why?
| Risk | 1 | 2007 | 819 | 0.060 |
Why?
| Motivation | 1 | 2009 | 498 | 0.060 |
Why?
| Spine | 1 | 2006 | 141 | 0.060 |
Why?
| Water | 1 | 2008 | 412 | 0.060 |
Why?
| Single-Blind Method | 1 | 2005 | 255 | 0.060 |
Why?
| Fluoride Poisoning | 1 | 2004 | 4 | 0.060 |
Why?
| Resuscitation | 1 | 2006 | 247 | 0.060 |
Why?
| Guidelines as Topic | 1 | 2005 | 248 | 0.060 |
Why?
| Pregnancy | 3 | 2021 | 5548 | 0.060 |
Why?
| Maltose | 1 | 2023 | 5 | 0.060 |
Why?
| Hydroxyzine | 1 | 2023 | 6 | 0.060 |
Why?
| Health Policy | 1 | 2006 | 334 | 0.060 |
Why?
| Magnesium | 1 | 2004 | 145 | 0.060 |
Why?
| Mycophenolic Acid | 1 | 2004 | 81 | 0.060 |
Why?
| Sheep | 1 | 2006 | 764 | 0.050 |
Why?
| Aspirin | 1 | 2006 | 326 | 0.050 |
Why?
| Urea | 1 | 2023 | 69 | 0.050 |
Why?
| Survival | 1 | 2003 | 37 | 0.050 |
Why?
| Patient Participation | 1 | 2006 | 363 | 0.050 |
Why?
| Prevalence | 3 | 2015 | 2264 | 0.050 |
Why?
| Internet | 1 | 2007 | 602 | 0.050 |
Why?
| Urban Population | 2 | 2019 | 405 | 0.050 |
Why?
| Lactates | 1 | 2022 | 83 | 0.050 |
Why?
| Canada | 1 | 2023 | 335 | 0.050 |
Why?
| Sex Distribution | 2 | 2015 | 337 | 0.050 |
Why?
| Culture Techniques | 1 | 2001 | 80 | 0.050 |
Why?
| Breast Neoplasms | 1 | 2013 | 1872 | 0.050 |
Why?
| Blood Physiological Phenomena | 1 | 2021 | 14 | 0.050 |
Why?
| Neural Conduction | 1 | 2001 | 79 | 0.050 |
Why?
| Academic Medical Centers | 2 | 2016 | 414 | 0.050 |
Why?
| Hirudins | 1 | 2021 | 46 | 0.050 |
Why?
| Controlled Clinical Trials as Topic | 1 | 2020 | 27 | 0.040 |
Why?
| Infusions, Parenteral | 1 | 2020 | 38 | 0.040 |
Why?
| Certification | 1 | 2020 | 90 | 0.040 |
Why?
| Pirenzepine | 1 | 1999 | 8 | 0.040 |
Why?
| Ambulatory Care | 1 | 2023 | 478 | 0.040 |
Why?
| Scorpions | 1 | 1999 | 2 | 0.040 |
Why?
| Immunosuppressive Agents | 1 | 2004 | 666 | 0.040 |
Why?
| Temperature | 1 | 2022 | 587 | 0.040 |
Why?
| South America | 1 | 1999 | 53 | 0.040 |
Why?
| Blood Cell Count | 2 | 2013 | 52 | 0.040 |
Why?
| Narcotics | 1 | 1999 | 45 | 0.040 |
Why?
| Postprandial Period | 1 | 2019 | 88 | 0.040 |
Why?
| Biological Availability | 1 | 2019 | 119 | 0.040 |
Why?
| Rupture, Spontaneous | 1 | 1998 | 16 | 0.040 |
Why?
| Manikins | 1 | 2018 | 24 | 0.040 |
Why?
| Videotape Recording | 1 | 2018 | 30 | 0.040 |
Why?
| Central Nervous System Depressants | 1 | 1999 | 82 | 0.040 |
Why?
| Sorption Detoxification | 1 | 1998 | 3 | 0.040 |
Why?
| Analysis of Variance | 1 | 2001 | 1227 | 0.040 |
Why?
| Dietary Proteins | 1 | 2019 | 123 | 0.040 |
Why?
| Lipids | 1 | 2022 | 588 | 0.040 |
Why?
| North America | 1 | 1999 | 261 | 0.040 |
Why?
| Cholinesterase Inhibitors | 1 | 1998 | 25 | 0.040 |
Why?
| Laparotomy | 1 | 1998 | 96 | 0.040 |
Why?
| Feedback | 1 | 2018 | 148 | 0.040 |
Why?
| Recombinant Proteins | 1 | 2021 | 1243 | 0.040 |
Why?
| Cross-Over Studies | 1 | 2019 | 434 | 0.040 |
Why?
| Maternal Health Services | 1 | 2019 | 81 | 0.040 |
Why?
| Central Nervous System | 1 | 1999 | 239 | 0.040 |
Why?
| Triglycerides | 1 | 2019 | 473 | 0.040 |
Why?
| Socioeconomic Factors | 2 | 2015 | 1086 | 0.040 |
Why?
| Registries | 2 | 2010 | 1770 | 0.040 |
Why?
| Bipolar Disorder | 1 | 1999 | 208 | 0.040 |
Why?
| Oxidation-Reduction | 1 | 2019 | 924 | 0.030 |
Why?
| Hallucinogens | 1 | 2017 | 73 | 0.030 |
Why?
| Dialysis | 1 | 2015 | 24 | 0.030 |
Why?
| Centrifugation | 1 | 2015 | 31 | 0.030 |
Why?
| Verapamil | 1 | 2014 | 32 | 0.030 |
Why?
| Tennessee | 1 | 1994 | 42 | 0.030 |
Why?
| Observation | 1 | 2014 | 50 | 0.030 |
Why?
| Hematocrit | 1 | 1994 | 86 | 0.030 |
Why?
| International Classification of Diseases | 1 | 2015 | 118 | 0.030 |
Why?
| Protein Binding | 1 | 2020 | 1917 | 0.030 |
Why?
| Program Evaluation | 1 | 2018 | 836 | 0.030 |
Why?
| Syndrome | 1 | 2015 | 339 | 0.030 |
Why?
| Anesthetics, Local | 1 | 2014 | 84 | 0.030 |
Why?
| Erythropoietin | 1 | 1994 | 72 | 0.030 |
Why?
| Warfare | 1 | 2014 | 75 | 0.030 |
Why?
| Injections, Intralesional | 1 | 2013 | 32 | 0.030 |
Why?
| Hospitals, Veterans | 1 | 1994 | 245 | 0.030 |
Why?
| Salicylates | 1 | 2013 | 30 | 0.030 |
Why?
| Urinalysis | 1 | 2013 | 62 | 0.030 |
Why?
| Iron | 1 | 1994 | 235 | 0.030 |
Why?
| Nursing Staff, Hospital | 1 | 1994 | 124 | 0.030 |
Why?
| Long QT Syndrome | 1 | 2013 | 59 | 0.030 |
Why?
| Hemoglobins | 1 | 1994 | 312 | 0.030 |
Why?
| Therapeutic Irrigation | 1 | 2012 | 67 | 0.030 |
Why?
| Receptors, Opioid, mu | 1 | 2012 | 52 | 0.020 |
Why?
| Cytochrome P-450 Enzyme System | 1 | 2012 | 108 | 0.020 |
Why?
| Computer Simulation | 1 | 2015 | 881 | 0.020 |
Why?
| Insulin Resistance | 1 | 2019 | 1078 | 0.020 |
Why?
| Vasculitis, Leukocytoclastic, Cutaneous | 1 | 2011 | 7 | 0.020 |
Why?
| False Negative Reactions | 1 | 2011 | 50 | 0.020 |
Why?
| Agranulocytosis | 1 | 2011 | 31 | 0.020 |
Why?
| Fluid Therapy | 1 | 2012 | 122 | 0.020 |
Why?
| Leukoencephalopathies | 1 | 2011 | 21 | 0.020 |
Why?
| Disease Outbreaks | 1 | 2014 | 308 | 0.020 |
Why?
| Toothache | 1 | 2010 | 5 | 0.020 |
Why?
| Gas Chromatography-Mass Spectrometry | 1 | 2011 | 125 | 0.020 |
Why?
| Quality of Health Care | 1 | 2015 | 576 | 0.020 |
Why?
| Immunoassay | 1 | 2011 | 97 | 0.020 |
Why?
| Models, Theoretical | 1 | 1994 | 519 | 0.020 |
Why?
| Drug Administration Routes | 1 | 2010 | 41 | 0.020 |
Why?
| Insurance Coverage | 1 | 2012 | 204 | 0.020 |
Why?
| Injections, Intravenous | 1 | 2010 | 204 | 0.020 |
Why?
| Neurologic Examination | 1 | 2010 | 116 | 0.020 |
Why?
| Patient Education as Topic | 1 | 1994 | 686 | 0.020 |
Why?
| Kidney Failure, Chronic | 1 | 1994 | 490 | 0.020 |
Why?
| Age Distribution | 1 | 2010 | 341 | 0.020 |
Why?
| Intestines | 1 | 2012 | 324 | 0.020 |
Why?
| Polymorphism, Genetic | 1 | 2012 | 621 | 0.020 |
Why?
| Precision Medicine | 1 | 2012 | 344 | 0.020 |
Why?
| Safety | 1 | 2010 | 298 | 0.020 |
Why?
| Ethanol | 1 | 2012 | 548 | 0.020 |
Why?
| Clinical Competence | 1 | 2014 | 912 | 0.020 |
Why?
| Triage | 1 | 2010 | 192 | 0.020 |
Why?
| Seasons | 1 | 2010 | 449 | 0.020 |
Why?
| Regression Analysis | 1 | 2010 | 959 | 0.020 |
Why?
| Disease Management | 1 | 2011 | 563 | 0.020 |
Why?
| Metabolomics | 1 | 2012 | 538 | 0.020 |
Why?
| Bilirubin | 1 | 2007 | 91 | 0.020 |
Why?
| Pulse | 1 | 2006 | 26 | 0.020 |
Why?
| Genotype | 1 | 2012 | 1786 | 0.020 |
Why?
| Blastomycosis | 1 | 2006 | 8 | 0.020 |
Why?
| Contraindications | 1 | 2006 | 86 | 0.020 |
Why?
| Amyloidosis | 1 | 2006 | 36 | 0.020 |
Why?
| Coronary Circulation | 1 | 2006 | 128 | 0.020 |
Why?
| Biopsy, Fine-Needle | 1 | 2006 | 64 | 0.020 |
Why?
| Infant, Newborn | 2 | 2007 | 5077 | 0.020 |
Why?
| Electric Countershock | 1 | 2006 | 104 | 0.020 |
Why?
| European Union | 1 | 2005 | 8 | 0.020 |
Why?
| Fever | 1 | 2007 | 280 | 0.020 |
Why?
| Disaster Planning | 1 | 2006 | 77 | 0.020 |
Why?
| Emergencies | 1 | 2006 | 147 | 0.020 |
Why?
| United States Food and Drug Administration | 1 | 2005 | 173 | 0.020 |
Why?
| Administration, Inhalation | 1 | 2006 | 644 | 0.020 |
Why?
| Renal Insufficiency | 1 | 2006 | 137 | 0.010 |
Why?
| Up-Regulation | 1 | 2007 | 820 | 0.010 |
Why?
| Swine | 1 | 2006 | 704 | 0.010 |
Why?
| Pharmaceutical Preparations | 1 | 2006 | 169 | 0.010 |
Why?
| Phenotype | 1 | 2012 | 2829 | 0.010 |
Why?
| Brain Injuries | 1 | 2009 | 451 | 0.010 |
Why?
| Mice, Inbred ICR | 1 | 2004 | 111 | 0.010 |
Why?
| Lupus Nephritis | 1 | 2004 | 52 | 0.010 |
Why?
| In Vitro Techniques | 1 | 2004 | 1044 | 0.010 |
Why?
| Blood Pressure | 1 | 2006 | 1537 | 0.010 |
Why?
| Miosis | 1 | 1999 | 3 | 0.010 |
Why?
| Pupil | 1 | 1999 | 13 | 0.010 |
Why?
| Hemodynamics | 1 | 2004 | 968 | 0.010 |
Why?
| Chronic Disease | 1 | 2004 | 1598 | 0.010 |
Why?
| Algorithms | 1 | 2004 | 1490 | 0.010 |
Why?
| Neoplasms | 1 | 2006 | 2118 | 0.010 |
Why?
|
|
Heard's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|